Clinical outcomes after long-term treatment with alglucosidase alfa in infants and children with advanced Pompe disease
Clinical outcomes after long-term treatment with alglucosidase alfa in infants and children with advanced Pompe disease is a paper indexed in PICO Portal from OpenAlex.
How many citations does Clinical outcomes after long-term treatment with alglucosidase alfa in infants and children with advanced Pompe disease have?
Clinical outcomes after long-term treatment with alglucosidase alfa in infants and children with advanced Pompe disease has 292 citations in the OpenAlex counts PICO Portal stores.
When was Clinical outcomes after long-term treatment with alglucosidase alfa in infants and children with advanced Pompe disease published?
Clinical outcomes after long-term treatment with alglucosidase alfa in infants and children with advanced Pompe disease has 2009 year in the PICO Portal index.
What is the open-access status of Clinical outcomes after long-term treatment with alglucosidase alfa in infants and children with advanced Pompe disease?
Clinical outcomes after long-term treatment with alglucosidase alfa in infants and children with advanced Pompe disease has bronze oa status in the PICO Portal index.
What is the DOI of Clinical outcomes after long-term treatment with alglucosidase alfa in infants and children with advanced Pompe disease?
The DOI for Clinical outcomes after long-term treatment with alglucosidase alfa in infants and children with advanced Pompe disease is on the source record.
What is the PMID of Clinical outcomes after long-term treatment with alglucosidase alfa in infants and children with advanced Pompe disease?
The PMID for Clinical outcomes after long-term treatment with alglucosidase alfa in infants and children with advanced Pompe disease is on the source record.
What is the OpenAlex record for Clinical outcomes after long-term treatment with alglucosidase alfa in infants and children with advanced Pompe disease?
The OpenAlex for Clinical outcomes after long-term treatment with alglucosidase alfa in infants and children with advanced Pompe disease is on the source record.